Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Research & Development (2021 - 2025)

Nexgel (NXGL) has disclosed Research & Development for 5 consecutive years, with $7000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development changed N/A year-over-year to $7000.0, compared with a TTM value of $8000.0 through Sep 2025, down 91.21%, and an annual FY2024 reading of $78000.0, down 24.27% over the prior year.
  • Research & Development was $7000.0 for Q3 2025 at Nexgel, up from $1000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $193000.0 in Q3 2022 and bottomed at $1000.0 in Q1 2025.
  • Average Research & Development over 5 years is $39133.3, with a median of $14000.0 recorded in 2021.
  • The sharpest move saw Research & Development surged 1010.0% in 2022, then tumbled 96.89% in 2023.
  • Year by year, Research & Development stood at $14000.0 in 2021, then skyrocketed by 178.57% to $39000.0 in 2022, then crashed by 66.67% to $13000.0 in 2023, then soared by 484.62% to $76000.0 in 2024, then crashed by 90.79% to $7000.0 in 2025.
  • Business Quant data shows Research & Development for NXGL at $7000.0 in Q3 2025, $1000.0 in Q1 2025, and $76000.0 in Q2 2024.